$0.82
(0.82%)
0.21%
Create an alert
Stocks and Shares ISALantheus Holdings, Inc. is a radiopharmaceutical-focused company, dedicated to helping clinicians find, fight, and follow disease to deliver better patient outcomes. Its product categories include oncology, neurology, cardiology, and strategic partnerships and others. Its products include PYLARIFY, Neuraceq, and DEFINITY. PYLARIFY TruVu is indicated for PET imaging of PSMA-positive lesions in men with prostate cancer with suspected metastasis who are candidates for initial definitive therapy, or suspected recurrence based on elevated serum prostate-specific antigen (PSA). Neuraceq is an Alzheimer's disease radiodiagnostic. Its commercial products are used by cardiologists, internists, neurologists, nuclear medicine physicians, oncologists, radiologists, sonographers, technologists, and urologists across a range of clinical care settings. Its diagnostic products provide information that enables healthcare professionals (HCPs) to better detect, characterize, or rule out diseases.
Company Information
About this company
Key people
Mary Anne Heino
Executive Chairman of the Board, Interim Executive Officer
Minnie Baylor-Henry
Independent Director
Gerard Ber
Independent Director
Julie Eastland
Independent Director
Samuel R. Leno
Independent Director
Robert J. Marshall
Chief Financial Officer, Treasurer
Jamie Spaeth
Chief People Officer
Daniel M. Niedzwiecki
Chief Administrative Officer, General Counsel, Corporate Secretary
Jean-Claude Provost
Chief Scientific Officer
Cheryl Ball
Chief Strategy Officer and Head of Corporate Development
Ludger Dinkelborg
Head of Research and Development
Amanda Morgan
Chief Commercial Officer
Julie H. Mchugh
Lead Independent Director
Click to see more
Key facts
- Shares in issue72.35m
- EPICLNTH
- ISINUS5165441032
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$6.45bn
- Employees1,193
- ExchangeNASDAQ
- IndexS&P 400 Mid Cap, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.